Viewing Study NCT03622593


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-02-21 @ 9:24 PM
Study NCT ID: NCT03622593
Status: COMPLETED
Last Update Posted: 2025-07-11
First Post: 2018-08-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
Sponsor: Hoffmann-La Roche
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: GR40398
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators